Table 1.
Univariate analyses of clinical features contributing to DUSP9 expression
| Factor | N=48 | Percent | P value | |
|---|---|---|---|---|
| Gender | male | 43 | 89.6% | 0.687 |
| female | 5 | 10.4% | ||
| Age | 0.885 | |||
| Stage | II | 2 | 4.2% | 0.149 |
| III | 10 | 20.8% | ||
| IV | 36 | 75.0% | ||
| Grade | low | 10 | 20.8% | 0.166 |
| low-medium | 7 | 14.6% | ||
| medium | 28 | 58.3% | ||
| high | 3 | 6.3% | ||
| Site | paranasal sinus | 3 | 6.3% | 0.099 |
| larynx | 36 | 75.0% | ||
| pharynx | 9 | 18.8% | ||
| Surgery | no | 0 | 0% | # |
| yes | 48 | 100.0% | ||
| Immunotherapy | no | 45 | 93.8% | 0.06 |
| yes | 3 | 6.3% | ||
| Chemotherapy | no | 44 | 91.7% | 0.135 |
| yes | 4 | 8.3% | ||
| Pulmonary Embolism | no | 43 | 89.6% | 0.88 |
| yes | 5 | 10.4% | ||
| Hypertension | no | 35 | 72.9% | 0.109 |
| yes | 13 | 27.1% | ||
| Diabetes | no | 43 | 89.6% | 0.037 |
| yes | 5 | 10.4% | ||
| Coronary Disease | no | 45 | 93.8% | 0.696 |
| yes | 3 | 6.3% | ||
| Smoking | no | 17 | 35.4% | 0.185 |
| yes | 31 | 64.6% | ||
| Alcohol | no | 20 | 41.7% | 0.215 |
| yes | 28 | 58.3% | ||
| HPV | HPV (-) | 44 | 91.7% | 0.171 |
| HPV (+) | 4 | 8.3% | ||
# Unable to compute due to numerical problems